Ropes & Gray represented Apollo Therapeutics in the transaction. Apollo Therapeutics Group Limited (“Apollo”) and Sunshine Lake Pharma Co., Ltd. have entered into an exclusive license...
Apollo Therapeutics’ Exclusive License Agreement with Sunshine Lake Pharma
H.I.G. Capital and Thoma Bravo’s Acquisition of CompTIA
Ropes & Gray, and Polsinelli are serving as advisors to H.I.G. and Thoma Bravo, while Husch Blackwell is serving as legal advisor to Comptia. H.I.G. Capital...
Bluecat Networks’ Acquisition of LiveAction
Ropes & Gray represented Bluecat Networks in the transaction. Bluecat Networks (BlueCat) announced its acquisition of LiveAction, a global provider of network observability and intelligence solutions....
AvenCell Therapeutics’ $112 Million Series B Funding Round
Ropes & Gray represented AvenCell Therapeutics in the transaction, and Wilson Sonsini Goodrich & Rosati advised Novo Holdings and F-Prime Capital on the transaction. AvenCell Therapeutics...
Insight Partners’ $1.5 Billion Continuation Fund III
Willkie Farr & Gallagher advised Insight Partners on the deal, and Ropes & Gray advised HarbourVest Partners. Insight Partners announced the closing of Continuation Fund III,...
Serán Bioscience’s $200 Million Growth Transaction
Ropes & Gray represented Bain Capital Life Sciences in the transaction. Serán Bioscience (“Serán”), a leading contract development and manufacturing organization (CDMO), announced a strategic growth...
Vir Biotechnology’s License Agreement with Sanofi
Ropes & Gray represented Vir Biotechnology in the transaction. Vir Biotechnology (Nasdaq: VIR) announced it has entered into an exclusive worldwide license agreement with Sanofi for...
Berkshire Partners’ Investment in Vital Care
Ropes & Gray represented Berkshire Partners in the transaction. Berkshire Partners (“Berkshire”) announced its strategic investment alongside Leonard Green & Partners (“Linden”) in Vital Care, an...
MiddleGround Capital’s Acquisition of The L.S. Starrett Company
Dechert advised MiddleGround Capital, while Ropes & Gray served as legal counsel to Starrett on the deal. MiddleGround Capital, a private equity firm, announced their definitive...
Allorion Therapeutics’ Licensing Agreement with Avenzo Therapeutics
Ropes & Gray advised Allorion Therapeutics on the transaction. Allorion Therapeutics (Allorion) announced it entered into a global licensing agreement with Avenzo Therapeutics Inc. (Avenzo) to develop and...
Nippon Steel Corporation’s $14 Billion Acquisition Of United States Steel Corporation
Ropes & Gray LLP acted as legal advisor to NSC, while Milbank LLP and Wachtell, Lipton, Rosen & Katz acted as legal advisors to U. S....
Audax Private Equity’s Investment in BlueCat Networks
Ropes & Gray represented Audax Private Equity, while Kirkland & Ellis represented BlueCat and MDP in the transaction. Audax Private Equity executed an investment in BlueCat...